Related references
Note: Only part of the references are listed.GAD-alum treatment induces GAD(65)-specific CD4(+)CD25(high)FOXP3(+) cells in type 1 diabetic patients
Maria Hjorth et al.
CLINICAL IMMUNOLOGY (2011)
Evidence That Nasal Insulin Induces Immune Tolerance to Insulin in Adults With Autoimmune Diabetes
Spiros Fourlanos et al.
DIABETES (2011)
Extended evaluation of the safety and efficacy of GAD treatment of children and adolescents with recent-onset type 1 diabetes: a randomised controlled trial
J. Ludvigsson et al.
DIABETOLOGIA (2011)
Type 1 diabetes vaccine development Animal models vs. humans
Tobias Boettler et al.
HUMAN VACCINES (2011)
Closed-loop insulin delivery: from bench to clinical practice
Roman Hovorka
NATURE REVIEWS ENDOCRINOLOGY (2011)
GAD-alum treatment in patients with type 1 diabetes and the subsequent effect on GADA IgG subclass distribution, GAD65 enzyme activity and humoral response
Mikael Cheramy et al.
CLINICAL IMMUNOLOGY (2010)
Autoimmunity and the pathogenesis of type 1 diabetes
Thomas R. Csorba et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2010)
Virus Infections and Type 1 Diabetes Risk
Merja Roivainen et al.
CURRENT DIABETES REPORTS (2010)
Recurrence of Type 1 Diabetes After Simultaneous Pancreas-Kidney Transplantation, Despite Immunosuppression, Is Associated With Autoantibodies and Pathogenic Autoreactive CD4 T-Cells
Francesco Vendrame et al.
DIABETES (2010)
Enterovirus Infection and Progression From Islet Autoimmunity to Type 1 Diabetes The Diabetes and Autoimmunity Study in the Young (DAISY)
Lars C. Stene et al.
DIABETES (2010)
Diabetes Antibody Standardization Program: evaluation of assays for insulin autoantibodies
M. Schlosser et al.
DIABETOLOGIA (2010)
Immunomodulation for type 1 diabetes mellitus
J. S. Skyler
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2010)
Changes in GAD65Ab-Specific Antiidiotypic Antibody Levels Correlate with Changes in C-Peptide Levels and Progression to Islet Cell Autoimmunity
E. Ortqvist et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Harmonization of Glutamic Acid Decarboxylase and Islet Antigen-2 Autoantibody Assays for National Institute of Diabetes and Digestive and Kidney Diseases Consortia
Ezio Bonifacio et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Disease progression and search for monogenic diabetes among children with new onset type 1 diabetes negative for ICA, GAD- and IA-2 Antibodies
Sven Porksen et al.
BMC ENDOCRINE DISORDERS (2010)
Novel antigens in type 1 diabetes: The importance of ZnT8
Janet M. Wenzlau et al.
CURRENT DIABETES REPORTS (2009)
Pancreatic Islet Autoantibodies as Predictors of Type 1 Diabetes in the Diabetes Prevention Trial-Type 1
Tihamer Orban et al.
DIABETES CARE (2009)
Anti-CD3 mAbs for treatment of type 1 diabetes
Adam Kaufman et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2009)
Endocrine autoimmunity in families with type 1 diabetes: frequent appearance of thyroid autoimmunity during late childhood and adolescence
E. Bonifacio et al.
DIABETOLOGIA (2009)
GAD65 vaccination: 5 years of follow-up in a randomised dose-escalating study in adult-onset autoimmune diabetes
C. -D. Agardh et al.
DIABETOLOGIA (2009)
Virus-like particle vaccines and adjuvants: the HPV paradigm
Franco Maria Buonaguro et al.
EXPERT REVIEW OF VACCINES (2009)
Latent Autoimmune Diabetes in Adults
Ramachandra G. Naik et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study
Christopher C. Patterson et al.
LANCET (2009)
Genetics of Type 1A Diabetes
Patrick Concannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
Mark D. Pescovitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
T Cells in the Pathogenesis of Type 1 Diabetes
Roberto Mallone et al.
CURRENT DIABETES REPORTS (2008)
Restoring a functional β-cell mass in diabetes
D. Pipeleers et al.
DIABETES OBESITY & METABOLISM (2008)
Diabetes classification: grey zones, sound and smoke: Action LADA 1
R. D. G. Leslie et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2008)
Children developing type 1 diabetes before 6 years of age have increased linear growth independent of HLA genotypes
H. Elding Larsson et al.
DIABETOLOGIA (2008)
Antigen presentation of detergent-free glutamate decarboxylase (GAD65) is affected by human serum albumin as carrier protein
Jordan Steed et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2008)
Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial
Kirsti Nanto-Salonen et al.
LANCET (2008)
GAD treatment and insulin secretion in recent-onset type 1 diabetes
Johnny Ludvigsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes
Shilpa Oak et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Multiple factors affect the loss of measurable C-peptide over 6 years in newly diagnosed 15- to 35-year-old diabetic subjects
Richard A. Jensen et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2007)
Effect of heat shock protein peptide DiaPep277 on β-cell function in paediatric and adult patients with recent-onset diabetes mellitus type 1:: two prospective, randomized, double-blind phase II trials
Nanette C. Schloot et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2007)
GAD65 autoantibody epitopes in adult patients with latent autoimmune diabetes following GAD65 vaccination
L. M. Bekris et al.
DIABETIC MEDICINE (2007)
Screening for insulitis in adult autoantibody-positive organ donors
Peter In't Veld et al.
DIABETES (2007)
Immunomodulation with human recombinant autoantigens
Å Lernmark et al.
TRENDS IN IMMUNOLOGY (2005)
Clinical evidence for the safety of GAD65 immunomodulation in adult-onset autoimmune diabetes
CD Agardh et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2005)
GAD65 antibody epitope patterns of type 1.5 diabetic patients are consistent with slow-onset autoinimune diabetes
CS Hampe et al.
DIABETES CARE (2002)
Suppressive, effect of glutamic acid decarboxylase 65-specific autoimmune B lymphocytes on processing of T cell determinants located within the antibody epitope
JC Jaume et al.
JOURNAL OF IMMUNOLOGY (2002)
Share Paper
